Ledger.Open graph →
SEC Form D · Amendment · filed March 9, 2022

Replicate Bioscience, Inc

Offering
$53.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Joseph Yanchik · San Diego, CADirectorMichael Ehlers · San Diego, CAExec · DirectorSeth Harrison · San Diego, CADirectorNathaniel Wang · San Diego, CAExec · DirectorHana Choe · Dallas, TXDirectorJames J. Frischling · Richmond, VAExec · DirectorJ. Andrew Thomas · Dallas, TXDirectorJohn Watson · Erie, COExec · DirectorOptima Managers GP-Mm LLC · New York, NYDirectorOptima Asset Management LLC · New York, NYExec · DirectorDerek Mitzel · Chandler, AZExec · DirectorLaura Robertson · Chandler, AZDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗